BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38603854)

  • 1. Synergistic action of Hedyotis diffusa Willd and Andrographis paniculata in Nasopharyngeal Carcinoma: Downregulating AKT1 and upregulating VEGFA to curb tumorigenesis.
    Ye C; Zhang B; Tang Z; Zheng C; Wang Q; Tong X
    Int Immunopharmacol; 2024 May; 132():111866. PubMed ID: 38603854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the Multi-Target Pharmacological Mechanism of
    Song Y; Wang H; Pan Y; Liu T
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
    [No Abstract]   [Full Text] [Related]  

  • 3. Hedyotis diffusae Herba-Andrographis Herba inhibits the cellular proliferation of nasopharyngeal carcinoma and triggers DNA damage through activation of p53 and p21.
    Liu Z; Mu S; Li S; Liang J; Deng Y; Yang Z; Li J; Cao L; Fu Q; Chen X; Ding L; Han R; Zhang Q; Xie H
    Cancer Gene Ther; 2022 Jul; 29(7):973-983. PubMed ID: 34754077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling.
    Wu A; Luo N; Xu Y; Du N; Li L; Liu Q
    Int J Biol Sci; 2022; 18(1):242-260. PubMed ID: 34975330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedyotis diffusa Willd extract suppresses Sonic hedgehog signaling leading to the inhibition of colorectal cancer angiogenesis.
    Lin J; Wei L; Shen A; Cai Q; Xu W; Li H; Zhan Y; Hong Z; Peng J
    Int J Oncol; 2013 Feb; 42(2):651-6. PubMed ID: 23291612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
    Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
    Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedyotis diffusa Willd and Astragalus membranaceus May Exert Anti-colon Cancer Effects by Affecting AKTI Expression, as Determined by Network Pharmacology and Molecular Docking.
    Ren J; Mo Z; Huang Z; Li S
    Curr Comput Aided Drug Des; 2024 Apr; ():. PubMed ID: 38638040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
    Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J
    Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scutellaria barbata and Hedyotis diffusa herb pair for breast cancer treatment: Potential mechanism based on network pharmacology.
    Ma TT; Zhang GL; Dai CF; Zhang BR; Cao KX; Wang CG; Yang GW; Wang XM
    J Ethnopharmacol; 2020 Sep; 259():112929. PubMed ID: 32416245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
    Zhang L; Zhang J; Qi B; Jiang G; Liu J; Zhang P; Ma Y; Li W
    J Ethnopharmacol; 2016 Nov; 192():132-139. PubMed ID: 27426510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology and experimental validation to identify the potential mechanism of Hedyotis diffusa Willd against rheumatoid arthritis.
    Deng H; Jiang J; Zhang S; Wu L; Zhang Q; Sun W
    Sci Rep; 2023 Jan; 13(1):1425. PubMed ID: 36697436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3.
    Zheng ZQ; Li ZX; Zhou GQ; Lin L; Zhang LL; Lv JW; Huang XD; Liu RQ; Chen F; He XJ; Kou J; Zhang J; Wen X; Li YQ; Ma J; Liu N; Sun Y
    Cancer Res; 2019 Sep; 79(18):4612-4626. PubMed ID: 31331909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
    Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
    Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
    Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Study of the Effect of Hedyotis diffusa on the Proliferation and the Apoptosis of the Cervical Tumor in Nude Mouse Model.
    Zhang P; Zhang B; Gu J; Hao L; Hu F; Han C
    Cell Biochem Biophys; 2015 Jul; 72(3):783-9. PubMed ID: 25677988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factor.
    Mao Y; Zhang DW; Wen J; Cao Q; Chen RJ; Zhu J; Feng ZQ
    Int J Mol Sci; 2012; 13(2):2208-2218. PubMed ID: 22408448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma.
    Xiong W; Li D; Ao F; Tu Z; Xiong J
    Cell Biochem Funct; 2024 Mar; 42(2):e3939. PubMed ID: 38454810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Pharmacology-Based Approach to Investigate the Mechanisms of
    Liu X; Wu J; Zhang D; Wang K; Duan X; Meng Z; Zhang X
    Evid Based Complement Alternat Med; 2018; 2018():7802639. PubMed ID: 29853970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.